Vivozon Healthcare Inc Net Assets

Latest as of June 2026: ₩95.30 Billion KRW ≈ $64.59 Million USD

Vivozon Healthcare Inc net assets. Based on the latest financial reports, Vivozon Healthcare Inc (082800) has net assets worth ₩95.30 Billion KRW (≈ $64.59 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩163.53 Billion ≈ $110.82 Million USD) and total liabilities (₩68.23 Billion ≈ $46.24 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Vivozon Healthcare Inc net asset momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩95.30 Billion
% of Total Assets	58.28%
Annual Growth Rate	2.46%
5-Year Change	-14.63%
10-Year Change	219.51%
Growth Volatility	91.68

Net Assets of Vivozon Healthcare Inc (2009–2025)

Net assets of Vivozon Healthcare Inc from 2009 to 2025. This chart illustrates how Vivozon Healthcare Inc's net assets have evolved over time, based on quarterly financial data. See Vivozon Healthcare Inc net asset quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Vivozon Healthcare Inc (2009–2025)

The table below shows the annual net assets of Vivozon Healthcare Inc from 2009 to 2025. For live market cap and overall valuation, see Vivozon Healthcare Inc stock valuation.

Year	Net Assets	Change
2025-12-31	₩72.66 Billion ≈ $49.24 Million	-31.72%
2024-12-31	₩106.43 Billion ≈ $72.12 Million	+2.27%
2023-12-31	₩104.07 Billion ≈ $70.52 Million	-1.67%
2022-12-31	₩105.84 Billion ≈ $71.72 Million	+24.34%
2021-12-31	₩85.12 Billion ≈ $57.68 Million	-21.04%
2020-12-31	₩107.80 Billion ≈ $73.06 Million	-1.10%
2019-12-31	₩109.00 Billion ≈ $73.87 Million	+59.24%
2018-12-31	₩68.45 Billion ≈ $46.38 Million	+325.14%
2017-12-31	₩16.10 Billion ≈ $10.91 Million	-29.21%
2016-12-31	₩22.74 Billion ≈ $15.41 Million	-7.75%
2015-12-31	₩24.65 Billion ≈ $16.71 Million	-27.27%
2014-12-31	₩33.90 Billion ≈ $22.97 Million	-39.63%
2010-12-31	₩56.15 Billion ≈ $38.05 Million	+14.05%
2009-12-31	₩49.23 Billion ≈ $33.37 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Vivozon Healthcare Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 111108.9% over the analyzed period, potentially due to dividend distributions or operating losses.

Vivozon Healthcare Inc Net Assets Breakdown (December 2025)

Vivozon Healthcare Inc net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Other Components	₩376.46 Billion	518.07%
Total Equity	₩72.66 Billion	100.00%

Vivozon Healthcare Inc Competitors by Market Cap

The table below lists competitors of Vivozon Healthcare Inc ranked by their market capitalization.

Company	Market Cap
Compugen TA:CGEN	$157.73 Million
AN2 Therapeutics Inc NASDAQ:ANTX	$157.74 Million
Ram Essential Services Property Fund AU:REP	$157.77 Million
Adagene Inc NASDAQ:ADAG	$157.79 Million
Sutro Biopharma NASDAQ:STRO	$157.69 Million
Agora S.A. WAR:AGO	$157.68 Million
Wintec Co. Ltd KQ:320000	$157.65 Million
Shanghai Longyun Advg & Media SHG:603729	$157.62 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Vivozon Healthcare Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 106,426,761,450 to 72,664,636,240, a change of -33,762,125,210 (-31.7%).
Net loss of 32,424,112,960 reduced equity.
Other factors decreased equity by 1,338,012,250.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩-32.42 Billion	-44.62%
Other Changes	₩-1.34 Billion	-1.84%
Total Change	₩-	-31.72%

Book Value vs Market Value Analysis

This analysis compares Vivozon Healthcare Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.25x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 5.21x to 2.25x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩599.47	₩3125.00	x
2017-12-31	₩424.37	₩3125.00	x
2018-12-31	₩919.23	₩3125.00	x
2019-12-31	₩905.06	₩3125.00	x
2020-12-31	₩766.46	₩3125.00	x
2021-12-31	₩2504.91	₩3125.00	x
2022-12-31	₩2261.07	₩3125.00	x
2023-12-31	₩2158.54	₩3125.00	x
2024-12-31	₩2026.75	₩3125.00	x
2025-12-31	₩1391.90	₩3125.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Vivozon Healthcare Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -44.62%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -54.64%
• Asset Turnover: 0.36x
• Equity Multiplier: 2.28x
Recent ROE (-44.62%) is below the historical average (-28.97%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	-3.83%	-1.08%	2.24x	1.58x	₩-4.69 Billion
2015	-39.34%	-10.81%	1.84x	1.98x	₩-12.16 Billion
2016	-7.83%	-2.61%	1.63x	1.85x	₩-4.06 Billion
2017	-41.42%	-10.93%	1.68x	2.26x	₩-8.28 Billion
2018	-12.47%	-18.55%	0.46x	1.47x	₩-15.38 Billion
2019	-25.69%	-62.28%	0.27x	1.51x	₩-38.90 Billion
2020	-40.59%	-100.37%	0.18x	2.30x	₩-54.53 Billion
2021	-81.60%	-120.31%	0.30x	2.28x	₩-77.97 Billion
2022	-37.70%	-77.39%	0.28x	1.77x	₩-50.49 Billion
2023	-3.23%	-4.71%	0.41x	1.67x	₩-13.76 Billion
2024	-9.38%	-11.39%	0.47x	1.73x	₩-20.62 Billion
2025	-44.62%	-54.64%	0.36x	2.28x	₩-39.69 Billion

Industry Comparison

This section compares Vivozon Healthcare Inc's net assets metrics with peer companies in the Pharmaceuticals industry.

Industry Context

Industry: Pharmaceuticals
Average net assets among peers: $101,034,626,727
Average return on equity (ROE) among peers: 12.99%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Vivozon Healthcare Inc (082800)	₩95.30 Billion	-3.83%	0.72x	$157.69 Million
Sam Chun Dang Pharm. Co. Ltd (000250)	$266.11 Billion	-4.10%	0.95x	$2.49 Billion
DongKoo Bio & Pharma Co. Ltd. (006620)	$2.55 Billion	158.01%	22.83x	$21.80 Million
NatureCell Co.Ltd (007390)	$13.75 Billion	13.78%	0.78x	$793.12 Million
Sam-A Pharm. Co. Ltd (009300)	$200.47 Billion	10.66%	0.15x	$56.13 Million
Kyung Dong Pharmaceutical Co. Ltd (011040)	$259.82 Billion	4.88%	0.12x	$78.42 Million
WooGene B&G Co. Ltd (018620)	$27.27 Billion	-46.89%	2.12x	$46.98 Million
Oscotec Inc (039200)	$21.78 Billion	-9.28%	0.67x	$674.16 Million
EstechPharma Co. Ltd (041910)	$115.63 Billion	3.31%	0.05x	$42.90 Million
Komipharm International Co. Ltd (041960)	$60.02 Billion	-6.63%	0.98x	$343.99 Million
Eagle Veterinary Technology Co.Ltd (044960)	$42.95 Billion	6.15%	0.28x	$25.96 Million

About Vivozon Healthcare Inc

KQ:082800 Korea Pharmaceuticals

Market Cap

$157.69 Million

₩232.69 Billion KRW

Market Cap Rank

#17269 Global

#689 in Korea

Share Price

₩3125.00

Change (1 day)

-2.80%

52-Week Range

₩2155.00 - ₩5750.00

All Time High

₩16500.00